Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Sector Forecast Shows Robust Momentum, Climbing to $62.82 Billion With 5.7% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market in 2026, and what figure is it projected to hit by 2030?
The chronic obstructive pulmonary disease (copd) and asthma devices market has experienced robust expansion over recent years. This market is projected to expand from $47.56 billion in 2025 to $50.3 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 5.8%. Historically, this growth can be ascribed to several factors, including the increasing occurrence of asthma and COPD, higher levels of air pollution and smoking, the expanding adoption of inhalation therapy, the broadening of respiratory care offerings, and more effective diagnosis of chronic respiratory conditions.
The chronic obstructive pulmonary disease (copd) and asthma devices market size is projected to show significant expansion in the upcoming years. It is anticipated to grow to $62.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This growth during the forecast period is attributable to an aging demographic with elevated respiratory risks, an increasing need for home care respiratory equipment, rising awareness regarding early respiratory disease management, the expansion of chronic disease management initiatives, and improved access to respiratory care in emerging markets. Noteworthy trends for the forecast period include the growing adoption of home-based respiratory care devices, increased demand for portable and user-friendly inhalation devices, a stronger focus on long-term disease management solutions, the broadened use of devices across pediatric and geriatric populations, and an intensified emphasis on treatment adherence and symptom control.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Which Drivers Are Affecting Market Participation In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The increasing incidence of respiratory ailments is projected to drive expansion within the chronic obstructive pulmonary disease (COPD) and asthma devices market in the future. Respiratory conditions involve numerous disorders affecting the lungs and respiratory pathways, including asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, which hinder breathing and overall respiratory performance. This rise in respiratory disease prevalence stems from escalating air pollution levels, shifting climatic patterns influencing allergens and pathogens, and lifestyle choices such as smoking that impair respiratory well-being. Devices for COPD and asthma are vital in the holistic management and treatment of these respiratory illnesses, assisting patients in attaining improved respiratory health and boosting their general welfare. For instance, in December 2023, the National Center for Biotechnology Information, a US-based government agency, projected that COPD cases would increase by 112 million, reaching a cumulative 592 million by 2050, constituting 9.5% of the eligible population. Consequently, the expanding occurrence of respiratory diseases fuels the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.
What Segment Categories Are Covered In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The chronic obstructive pulmonary disease (copd) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
What Long-Term Trends Are Expected To Shape The Future Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Key companies active in the chronic obstructive pulmonary disease and asthma devices market are concentrating on creating novel solutions like smart, sensor-equipped inhaler technologies. These innovations aim to enhance medication compliance, facilitate real-time symptom monitoring, and support tailored respiratory disease management. Smart inhaler technologies incorporate embedded sensors and digital connectivity to gather inhalation data, track patient usage habits, and provide actionable insights for both patients and healthcare professionals. For example, in July 2023, Teva UK Ltd., a UK-based pharmaceutical company, introduced GoResp Digihaler. This digitally connected inhaler is designed to record inhalation parameters, deliver immediate feedback, and promote better disease control through data-informed patient engagement. The device contributes to improved treatment results by enabling remote oversight, giving clinicians a clearer understanding of patient adherence trends, and strengthening long-term disease management for individuals suffering from chronic respiratory conditions.
Which Major Industry Participants Are Leading The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Growth?
Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd
Access The Complete Report For Deeper Market Insights:
Which Region Is Expected To Experience The Fastest Growth In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
Browse Through More Reports Similar to the Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market 2026, By The Business Research Company
High Performance Liquid Chromatography Global Market Report 2026
Analytical Laboratory Instrument Global Market Report 2026
Chromatography Software Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/chromatography-software-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company